Exact Mass: 431.1692

Exact Mass Matches: 431.1692

Found 88 metabolites which its exact mass value is equals to given mass value 431.1692, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ala Asn Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.1765)

Asp Asn Pro Ser

(3S)-3-amino-3-{[(2S)-3-carbamoyl-1-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}propanoic acid

C16H25N5O9 (431.1652)

Asp Asn Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O9 (431.1652)

Asp Pro Asn Ser

(3S)-3-amino-4-[(2S)-2-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O9 (431.1652)

Asp Pro Ser Asn

(3S)-3-amino-4-[(2S)-2-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O9 (431.1652)

Asp Ser Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O9 (431.1652)

Asp Ser Pro Asn

(3S)-3-amino-3-{[(2S)-1-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]carbamoyl}propanoic acid

C16H25N5O9 (431.1652)

Gly Asn Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C15H25N7O8 (431.1765)

Gly Asn Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.1765)

Gly Gln Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.1765)

Asn Ala Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.1765)

Asn Asp Pro Ser

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-4-[(2S)-2-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O9 (431.1652)

Asn Asp Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O9 (431.1652)

Asn Gly Asn Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C15H25N7O8 (431.1765)

Asn Gly Gln Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.1765)

Asn Asn Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]propanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.1765)

Asn Asn Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]acetamido}-4-carbamoylbutanoic acid

C15H25N7O8 (431.1765)

Asn Asn Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]propanoic acid

C15H25N7O8 (431.1765)

Asn Asn Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]acetic acid

C15H25N7O8 (431.1765)

Asn Pro Asp Ser

(3S)-3-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C16H25N5O9 (431.1652)

Asn Pro Ser Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]butanedioic acid

C16H25N5O9 (431.1652)

Asn Gln Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]acetamido}-3-carbamoylpropanoic acid

C15H25N7O8 (431.1765)

Asn Gln Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]acetic acid

C15H25N7O8 (431.1765)

Asn Ser Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O9 (431.1652)

Asn Ser Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C16H25N5O9 (431.1652)

Pro Asp Asn Ser

(3S)-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C16H25N5O9 (431.1652)

Pro Asp Ser Asn

(3S)-3-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C16H25N5O9 (431.1652)

Pro Asn Asp Ser

(3S)-3-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C16H25N5O9 (431.1652)

Pro Asn Ser Asp

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxypropanamido]butanedioic acid

C16H25N5O9 (431.1652)

Pro Ser Asp Asn

(3S)-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-3-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoic acid

C16H25N5O9 (431.1652)

Pro Ser Asn Asp

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanedioic acid

C16H25N5O9 (431.1652)

Gln Gly Asn Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C15H25N7O8 (431.1765)

Gln Asn Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]acetamido}-3-carbamoylpropanoic acid

C15H25N7O8 (431.1765)

Gln Asn Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]acetic acid

C15H25N7O8 (431.1765)

Ser Asp Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O9 (431.1652)

Ser Asp Pro Asn

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-4-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C16H25N5O9 (431.1652)

Ser Asn Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C16H25N5O9 (431.1652)

Ser Asn Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C16H25N5O9 (431.1652)

Ser Pro Asp Asn

(3S)-3-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C16H25N5O9 (431.1652)

Ser Pro Asn Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]butanedioic acid

C16H25N5O9 (431.1652)

Lys-TyrMe-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-4-(4-methoxyphenyl)butanoic acid

C21H25N3O7 (431.1692)

Tyr-Lys-OH

(S)-7-amino-2-(3-(4-hydroxyphenethoxy)-4-nitrobenzamido)heptanoic acid

C21H25N3O7 (431.1692)

L-Octahydroindole-2-carboxylic acid benzyl ester 4-methylbenzenesulfonate

C23H29NO5S (431.1766)

Fmoc-D-Tyr(4-Et)-OH

C26H25NO5 (431.1733)

H-Arg-Trp-NH2 · 2 HCl

C17H27Cl2N7O2 (431.1603)

Carbol Fuchsin

C26H26ClN3O (431.1764)

1,3,5,2,4,6-Triazatriphosphorine,2,2,4,4,6-pentakis(1-aziridinyl)-2,2,4,4,6,6-hexahydro-6-(4-morpholinyl)- (9CI)

C14H28N9OP3 (431.163)

Fmoc-2,6-dimethyl-L-tyrosine

C26H25NO5 (431.1733)

Fmoc-D-Thr(Bzl)-OH

C26H25NO5 (431.1733)

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-threonine phenylmethyl ester

C26H25NO5 (431.1733)

Fmoc-N-methyl-O-benzyl-L-serine

C26H25NO5 (431.1733)

Bay 65-1942 (hydrochloride)

C22H26ClN3O4 (431.1612)

Fmoc-AHPPA

C26H25NO5 (431.1733)

Fmoc-Thr(Bzl)-OH

C26H25NO5 (431.1733)

Xanomeline tartrate

C18H29N3O7S (431.1726)

D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs Xanomeline (LY 246708) is the potent agonist of muscarinic M1/M4 receptor with antipsychotic-like activity. Xanomeline (LY 246708) increases neuronal excitability. Xanomeline (LY 246708) can be used for the research of schizophrenia[1][2][3].

(2E,4E)-5-[(1R,7S,8S,9R)-7-acetyloxy-4-methoxycarbonyl-9-methyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate

C23H27O8- (431.1706)

N2,N5-Bis(3-acetamidophenyl)pyridine-2,5-dicarboxamide

C23H21N5O4 (431.1593)

5-Carboxy methylrhodamine

C25H23N2O5+ (431.1607)

4-Tert-butylbenzoic acid [2-[(2-methoxy-3-dibenzofuranyl)amino]-2-oxoethyl] ester

C26H25NO5 (431.1733)

2,5-diethoxy-N-[2-(2-methylphenyl)ethyl]-4-(1-tetrazolyl)benzenesulfonamide

C20H25N5O4S (431.1627)

Tyr-Ser-Tyr

C21H25N3O7 (431.1692)

18-(2-Methoxyphenyl)-15-phenyl-11-oxa-13,15-diazatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8,12(17),13-heptaen-16-imine

C28H21N3O2 (431.1634)

18-(3-Methoxyphenyl)-15-phenyl-11-oxa-13,15-diazatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8,12(17),13-heptaen-16-imine

C28H21N3O2 (431.1634)

(6R,7R,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H22FN3O3 (431.1645)

(6R,7R,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H22FN3O3 (431.1645)

(6R,7S,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H22FN3O3 (431.1645)

(6S,7S,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H22FN3O3 (431.1645)

(6R,7S,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H22FN3O3 (431.1645)

(6S,7S,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H22FN3O3 (431.1645)

(6S,7R,8R)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H22FN3O3 (431.1645)

(6S,7R,8S)-7-[4-(2-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[oxo(3-pyridinyl)methyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H22FN3O3 (431.1645)

Ser-Tyr-Tyr

C21H25N3O7 (431.1692)

Tyr-Tyr-Ser

C21H25N3O7 (431.1692)

ST 21:6;O2;Tau

C23H29NO5S (431.1766)

NVP 231

C25H25N3O2S (431.1667)

NVP 231 is a potent, specific, and reversible ceramide kinase (CerK) inhibitor(IC50=12 nM) that competitively inhibits binding of ceramide to CerK[1]. NVP 231 induces cell apoptosis by increasing DNA fragmentation and caspase-3 and caspase-9 cleavage[2].

9-hydroxy-9-({3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}methyl)-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

C23H21N5O4 (431.1593)

(2z,6e)-7-[(5r,5ar,6s,8as)-3-{[hydroxy(methoxy)methylidene]amino}-6-methyl-4-oxo-5h,5ah,6h,7h,8h,8ah,9h-cyclopenta[g]thiochromen-5-yl]-3-methylhepta-2,6-dienoic acid

C23H29NO5S (431.1766)

5,12-dihydroxy-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-6,9-diene-8,11-dione

C21H25N3O7 (431.1692)

(19s,21s,23r)-5,12-dihydroxy-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-6,9-diene-8,11-dione

C21H25N3O7 (431.1692)

(2s,9r,9as)-9-hydroxy-9-{[(4s)-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

C23H21N5O4 (431.1593)

(2s,9s,9ar)-9-hydroxy-9-{[(4s)-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-2-methyl-1h,2h,9ah-imidazo[1,2-a]indol-3-one

C23H21N5O4 (431.1593)

7-(3-{[hydroxy(methoxy)methylidene]amino}-6-methyl-4-oxo-5h,5ah,6h,7h,8h,8ah,9h-cyclopenta[g]thiochromen-5-yl)-3-methylhepta-2,6-dienoic acid

C23H29NO5S (431.1766)